Press Releases

    Print Page  Close Window
BioMed Realty Trust Announces Tax Treatment of 2007 Distributions
 BioMed Realty Trust, Inc.
(NYSE: BMR) today announced the tax treatment of its 2007 distributions as
follows:

                      Security Description: Common Stock
                               CUSIP: 09063H107
                              Ticker Symbol: BMR

                                   Total       Allocable
     Record       Payable       Distribution      to        Taxable Ordinary
      Date         Date          Per Share       2007          Dividend

    12/29/2006   1/16/2007       $0.290000    $0.290000        $0.237498
     3/30/2007   4/16/2007       $0.310000    $0.310000        $0.253877
     6/29/2007   7/16/2007       $0.310000    $0.310000        $0.237089
     9/28/2007  10/15/2007       $0.310000    $0.310000        $0.253877
             Totals              $1.220000    $1.220000        $0.982341


                                                             Unrecaptured
     Record       Payable        Return of    Long-Term      Section 1250
      Date         Date           Capital    Capital Gain        Gain

    12/29/2006   1/16/2007       $0.052502    $0.000000        $0.000000
     3/30/2007   4/16/2007       $0.056123    $0.000000        $0.000000
     6/29/2007   7/16/2007       $0.056123    $0.016788        $0.009224
     9/28/2007  10/15/2007       $0.056123    $0.000000        $0.000000
           Totals                $0.220871    $0.016788        $0.009224



 Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock
                               CUSIP: 09063H206
                           Ticker Symbol: BMR PR A

                                  Total                         Taxable
        Record     Payable     Distribution   Allocable        Ordinary
         Date       Date        Per Share      to 2007         Dividend

      3/30/2007   4/16/2007      $0.455820    $0.455820        $0.455820
      6/29/2007   7/16/2007      $0.455820    $0.455820        $0.432753
      9/28/2007  10/15/2007      $0.460940    $0.460940        $0.460940
             Totals              $1.372580    $1.372580        $1.349513



                                                              Unrecaptured
       Record       Payable      Return of     Long-Term       Section 1250
        Date         Date         Capital     Capital Gain        Gain

      3/30/2007   4/16/2007      $0.000000    $0.000000        $0.000000
      6/29/2007   7/16/2007      $0.000000    $0.023067        $0.012674
      9/28/2007  10/15/2007      $0.000000    $0.000000        $0.000000
              Totals             $0.000000    $0.023067        $0.012674



The distributions payable on January 15, 2008 to shareholders of record on December 31, 2007 are considered 2008 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2007. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.002 per common share and Series A preferred share attributable to depreciation, each assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 68 properties, representing 104 buildings with approximately 8.5 million rentable square feet, as well as approximately 1.9 million square feet of development in progress. These properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at http://www.biomedrealty.com.

CONTACT: Kent Griffin

Chief Financial Officer
(858) 485-9840

SOURCE BioMed Realty Trust, Inc.

http://www.biomedrealty.com